Use case · Pharma HEOR & Market Access

Evidence that moves at decision speed

Run systematic literature reviews and evidence landscapes fast enough to inform submissions, reimbursement strategy, and comparator decisions without compromising appraisal consistency or traceability.

Start a review Book a workflow demo

Who this supports

HEOR Director Outcome evidence, comparator narratives, payer logic.
Market Access Director Reimbursement support, value story, external scrutiny.

The problem

Evidence strategy cannot wait months for an SLR

HEOR and evidence teams run SLRs, evidence landscape reviews, and gap analyses on tight timelines. Speed usually means outsourcing the work or cutting methodological corners. Neither is acceptable when the output feeds submissions and strategy.

SLRs that take months and lock up specialists
Appraisal consistency that varies by reviewer and vendor
Evidence landscapes outdated by the time they land
Synthesis hard to trace back to source for QC

How Aibstracts fits

Move fast where the work is mechanical. Stay in control where it is methodological

Landscapes on demand

You scope a body of literature on demand, so evidence strategy rests on what the field shows right now, not last quarter.

SLRs without the wait

The mechanical work runs automatically while your specialists keep control of the methodology, so an SLR stops blocking the decisions that depend on it.

Consistency you can prove

The same decision rules apply to every study, and calibration puts a number on agreement, so appraisal quality no longer depends on which reviewer or vendor did the work.

QC without the archaeology

Every extracted fact and judgment links back to its source, so quality checks and re-review take minutes instead of reconstructing someone else’s reasoning.